In today’s pharmaceutical manufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products. The U.S.

It is not uncommon for people to sometimes take important things for granted, such as the quality of the medicines they rely on for their health. While not usually top-of-mind, standards and other quality-focused solutions developed by the U.S.

In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.

The field of biologics is vast and growing, with tremendous potential to improve patients’ lives and public health.